<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Epigenetic Modifications - Detailed</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            padding: 40px 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
        }
        
        .main-title {
            font-size: 32px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .overview-section {
            margin-bottom: 50px;
            padding: 30px;
            background: #f8f9fb;
            border-radius: 8px;
        }
        
        .content-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin-bottom: 50px;
        }
        
        .info-box {
            background: #f8f9fb;
            border-left: 4px solid #1E64C8;
            padding: 16px 18px;
            border-radius: 6px;
        }
        
        .info-title {
            font-size: 17px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 10px;
        }
        
        .info-content {
            font-size: 15px;
            color: #333;
            line-height: 1.5;
        }
        
        .bullet {
            display: flex;
            align-items: flex-start;
            margin-bottom: 6px;
        }
        
        .bullet::before {
            content: "•";
            color: #1E64C8;
            font-weight: bold;
            margin-right: 8px;
            font-size: 16px;
        }
        
        .detailed-section {
            margin-bottom: 60px;
            padding: 30px;
            background: white;
            border: 2px solid #e1e4e8;
            border-radius: 10px;
        }
        
        .section-title {
            font-size: 26px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 20px;
            padding-bottom: 10px;
            border-bottom: 3px solid #1E64C8;
        }
        
        .diagram-container {
            background: #f8f9fb;
            padding: 30px;
            border-radius: 8px;
            margin: 25px 0;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 300px;
        }
        
        .svg-diagram {
            width: 100%;
            max-width: 800px;
            height: auto;
        }
        
        .description {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
            margin-bottom: 15px;
        }
        
        .subsection {
            margin-top: 25px;
        }
        
        .subsection-title {
            font-size: 20px;
            font-weight: 600;
            color: #2c5aa0;
            margin-bottom: 12px;
        }
        
        .key-points {
            background: #e8f4f8;
            padding: 20px;
            border-radius: 6px;
            margin-top: 20px;
        }
        
        .key-points-title {
            font-size: 18px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 12px;
        }
        
        .key-point {
            display: flex;
            align-items: flex-start;
            margin-bottom: 10px;
            font-size: 15px;
            line-height: 1.6;
        }
        
        .key-point::before {
            content: "→";
            color: #1E64C8;
            font-weight: bold;
            margin-right: 10px;
            font-size: 18px;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1 class="main-title">Epigenetic Modifications: Detailed Overview</h1>
        
        <!-- Overview Section -->
        <div class="overview-section">
            <div class="content-grid">
                <div class="info-box">
                    <div class="info-title">DNA Methylation</div>
                    <div class="info-content">
                        <div class="bullet">Addition of methyl groups to cytosine</div>
                        <div class="bullet">CpG islands near promoters</div>
                        <div class="bullet">Gene silencing mechanism</div>
                        <div class="bullet">Maintained through cell division</div>
                    </div>
                </div>
                
                <div class="info-box">
                    <div class="info-title">Histone Modifications</div>
                    <div class="info-content">
                        <div class="bullet">Acetylation: gene activation</div>
                        <div class="bullet">Methylation: activation or repression</div>
                        <div class="bullet">Phosphorylation: chromatin structure</div>
                        <div class="bullet">Histone code hypothesis</div>
                    </div>
                </div>
                
                <div class="info-box">
                    <div class="info-title">Chromatin States</div>
                    <div class="info-content">
                        <div class="bullet">Euchromatin: transcriptionally active</div>
                        <div class="bullet">Heterochromatin: transcriptionally silent</div>
                        <div class="bullet">Dynamic transitions</div>
                        <div class="bullet">Cell type-specific patterns</div>
                    </div>
                </div>
                
                <div class="info-box">
                    <div class="info-title">Disease Implications</div>
                    <div class="info-content">
                        <div class="bullet">Cancer: aberrant methylation</div>
                        <div class="bullet">Imprinting disorders</div>
                        <div class="bullet">X-chromosome inactivation</div>
                        <div class="bullet">Environmental influences</div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 1: DNA Methylation -->
        <div class="detailed-section">
            <h2 class="section-title">1. DNA Methylation</h2>
            
            <div class="diagram-container">
                <svg class="svg-diagram" viewBox="0 0 800 280" xmlns="http://www.w3.org/2000/svg">
                    <!-- DNA Strand -->
                    <line x1="50" y1="140" x2="750" y2="140" stroke="#333" stroke-width="3"/>
                    <line x1="50" y1="160" x2="750" y2="160" stroke="#333" stroke-width="3"/>
                    
                    <!-- CpG Sites -->
                    <g id="cpg1">
                        <circle cx="150" cy="150" r="25" fill="#FF6B6B" opacity="0.3"/>
                        <text x="150" y="155" text-anchor="middle" font-size="16" font-weight="bold" fill="#333">CpG</text>
                    </g>
                    <g id="cpg2">
                        <circle cx="300" cy="150" r="25" fill="#FF6B6B" opacity="0.3"/>
                        <text x="300" y="155" text-anchor="middle" font-size="16" font-weight="bold" fill="#333">CpG</text>
                    </g>
                    <g id="cpg3">
                        <circle cx="450" cy="150" r="25" fill="#FF6B6B" opacity="0.3"/>
                        <text x="450" y="155" text-anchor="middle" font-size="16" font-weight="bold" fill="#333">CpG</text>
                    </g>
                    <g id="cpg4">
                        <circle cx="600" cy="150" r="25" fill="#FF6B6B" opacity="0.3"/>
                        <text x="600" y="155" text-anchor="middle" font-size="16" font-weight="bold" fill="#333">CpG</text>
                    </g>
                    
                    <!-- Methyl Groups -->
                    <g id="methyl1">
                        <circle cx="150" cy="100" r="15" fill="#4ECDC4"/>
                        <text x="150" y="105" text-anchor="middle" font-size="12" font-weight="bold" fill="white">CH₃</text>
                        <line x1="150" y1="115" x2="150" y2="125" stroke="#4ECDC4" stroke-width="2"/>
                    </g>
                    <g id="methyl2">
                        <circle cx="300" cy="100" r="15" fill="#4ECDC4"/>
                        <text x="300" y="105" text-anchor="middle" font-size="12" font-weight="bold" fill="white">CH₃</text>
                        <line x1="300" y1="115" x2="300" y2="125" stroke="#4ECDC4" stroke-width="2"/>
                    </g>
                    <g id="methyl3">
                        <circle cx="450" cy="100" r="15" fill="#4ECDC4"/>
                        <text x="450" y="105" text-anchor="middle" font-size="12" font-weight="bold" fill="white">CH₃</text>
                        <line x1="450" y1="115" x2="450" y2="125" stroke="#4ECDC4" stroke-width="2"/>
                    </g>
                    <g id="methyl4">
                        <circle cx="600" cy="100" r="15" fill="#4ECDC4"/>
                        <text x="600" y="105" text-anchor="middle" font-size="12" font-weight="bold" fill="white">CH₃</text>
                        <line x1="600" y1="115" x2="600" y2="125" stroke="#4ECDC4" stroke-width="2"/>
                    </g>
                    
                    <!-- Labels -->
                    <text x="400" y="30" text-anchor="middle" font-size="18" font-weight="bold" fill="#1E64C8">DNA Methylation at CpG Sites</text>
                    <text x="150" y="210" text-anchor="middle" font-size="14" fill="#666">Cytosine</text>
                    <text x="150" y="70" text-anchor="middle" font-size="14" fill="#4ECDC4" font-weight="bold">Methyl Group</text>
                    
                    <!-- Arrow indicating gene silencing -->
                    <path d="M 680 150 L 750 150 L 745 145 M 750 150 L 745 155" stroke="#FF6B6B" stroke-width="2" fill="none"/>
                    <text x="715" y="190" text-anchor="middle" font-size="14" fill="#FF6B6B" font-weight="bold">Gene</text>
                    <text x="715" y="205" text-anchor="middle" font-size="14" fill="#FF6B6B" font-weight="bold">Silencing</text>
                </svg>
            </div>
            
            <p class="description">
                DNA methylation is the most extensively studied epigenetic modification, involving the addition of a methyl group (CH₃) to the 5th carbon position of cytosine bases, primarily at CpG dinucleotides (cytosine-guanine sequences). This process is catalyzed by DNA methyltransferases (DNMTs) and serves as a stable, heritable mark that can be maintained through cell division.
            </p>
            
            <div class="subsection">
                <h3 class="subsection-title">Mechanism and Function</h3>
                <p class="description">
                    CpG islands are regions with high frequency of CpG sites, typically found near gene promoters. When methylated, these regions recruit methyl-binding proteins (MBDs) that block transcription factor access and recruit chromatin remodeling complexes, leading to gene silencing. This mechanism is crucial for normal development, genomic imprinting, and X-chromosome inactivation in females.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">Biological Significance</h3>
                <p class="description">
                    DNA methylation patterns are established during early development and maintained throughout cell division by maintenance methyltransferases like DNMT1. These patterns are cell-type specific and play critical roles in cellular differentiation, tissue-specific gene expression, and the silencing of repetitive DNA elements and transposons.
                </p>
            </div>
            
            <div class="key-points">
                <div class="key-points-title">Key Points:</div>
                <div class="key-point">DNMT1 maintains methylation patterns during DNA replication</div>
                <div class="key-point">DNMT3a and DNMT3b establish de novo methylation</div>
                <div class="key-point">Demethylation can occur passively or actively (TET enzymes)</div>
                <div class="key-point">Hypermethylation of tumor suppressor genes is common in cancer</div>
                <div class="key-point">Global hypomethylation can lead to chromosomal instability</div>
            </div>
        </div>

        <!-- Detailed Section 2: Histone Modifications -->
        <div class="detailed-section">
            <h2 class="section-title">2. Histone Modifications</h2>
            
            <div class="diagram-container">
                <svg class="svg-diagram" viewBox="0 0 800 320" xmlns="http://www.w3.org/2000/svg">
                    <!-- Nucleosome -->
                    <circle cx="400" cy="180" r="60" fill="#95E1D3" stroke="#333" stroke-width="2"/>
                    <text x="400" y="185" text-anchor="middle" font-size="14" font-weight="bold" fill="#333">Histone</text>
                    <text x="400" y="200" text-anchor="middle" font-size="14" font-weight="bold" fill="#333">Octamer</text>
                    
                    <!-- DNA wrapping -->
                    <path d="M 340 180 Q 320 140 340 100 Q 360 60 400 60 Q 440 60 460 100 Q 480 140 460 180" 
                          stroke="#1E64C8" stroke-width="4" fill="none"/>
                    <path d="M 340 180 Q 320 220 340 260 Q 360 300 400 300 Q 440 300 460 260 Q 480 220 460 180" 
                          stroke="#1E64C8" stroke-width="4" fill="none"/>
                    
                    <!-- Histone Tails -->
                    <line x1="340" y1="180" x2="280" y2="180" stroke="#333" stroke-width="3"/>
                    <line x1="460" y1="180" x2="520" y2="180" stroke="#333" stroke-width="3"/>
                    <line x1="400" y1="120" x2="400" y2="60" stroke="#333" stroke-width="3"/>
                    <line x1="400" y1="240" x2="400" y2="300" stroke="#333" stroke-width="3"/>
                    
                    <!-- Acetylation (Ac) -->
                    <circle cx="260" cy="180" r="12" fill="#FFD93D"/>
                    <text x="260" y="184" text-anchor="middle" font-size="10" font-weight="bold" fill="#333">Ac</text>
                    <text x="260" y="210" text-anchor="middle" font-size="12" fill="#FFD93D" font-weight="bold">Activation</text>
                    
                    <!-- Methylation (Me) -->
                    <circle cx="540" cy="180" r="12" fill="#FF6B9D"/>
                    <text x="540" y="184" text-anchor="middle" font-size="10" font-weight="bold" fill="white">Me</text>
                    <text x="540" y="210" text-anchor="middle" font-size="12" fill="#FF6B9D" font-weight="bold">Variable</text>
                    
                    <!-- Phosphorylation (P) -->
                    <circle cx="400" cy="40" r="12" fill="#C44569"/>
                    <text x="400" y="44" text-anchor="middle" font-size="10" font-weight="bold" fill="white">P</text>
                    <text x="440" y="30" text-anchor="start" font-size="12" fill="#C44569" font-weight="bold">Structure</text>
                    
                    <!-- Ubiquitination (Ub) -->
                    <circle cx="400" cy="320" r="12" fill="#6C5CE7"/>
                    <text x="400" y="324" text-anchor="middle" font-size="9" font-weight="bold" fill="white">Ub</text>
                    <text x="440" y="325" text-anchor="start" font-size="12" fill="#6C5CE7" font-weight="bold">Regulation</text>
                    
                    <!-- Title -->
                    <text x="400" y="25" text-anchor="middle" font-size="18" font-weight="bold" fill="#1E64C8">Histone Post-Translational Modifications</text>
                    
                    <!-- Legend -->
                    <rect x="50" y="50" width="150" height="100" fill="#f8f9fb" stroke="#ccc" stroke-width="1" rx="5"/>
                    <text x="125" y="70" text-anchor="middle" font-size="13" font-weight="bold" fill="#333">Modifications:</text>
                    <text x="60" y="90" font-size="11" fill="#333">• Ac: Acetylation</text>
                    <text x="60" y="105" font-size="11" fill="#333">• Me: Methylation</text>
                    <text x="60" y="120" font-size="11" fill="#333">• P: Phosphorylation</text>
                    <text x="60" y="135" font-size="11" fill="#333">• Ub: Ubiquitination</text>
                </svg>
            </div>
            
            <p class="description">
                Histone modifications are covalent post-translational modifications to histone proteins that regulate chromatin structure and gene expression. The N-terminal tails of histones extend from the nucleosome core and serve as platforms for various chemical modifications, including acetylation, methylation, phosphorylation, and ubiquitination.
            </p>
            
            <div class="subsection">
                <h3 class="subsection-title">Types of Modifications</h3>
                <p class="description">
                    <strong>Acetylation:</strong> Addition of acetyl groups by histone acetyltransferases (HATs) neutralizes positive charges on lysine residues, reducing histone-DNA interactions and promoting transcriptional activation. Histone deacetylases (HDACs) remove these marks to repress transcription.
                </p>
                <p class="description">
                    <strong>Methylation:</strong> Addition of methyl groups to lysine or arginine residues by histone methyltransferases (HMTs). Unlike acetylation, methylation can activate or repress transcription depending on the specific residue modified (e.g., H3K4me3 activates, H3K9me3 represses).
                </p>
                <p class="description">
                    <strong>Phosphorylation:</strong> Addition of phosphate groups by kinases, often involved in DNA damage response and chromosome condensation during mitosis.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">The Histone Code Hypothesis</h3>
                <p class="description">
                    The histone code hypothesis proposes that specific combinations of histone modifications create a "code" that is read by effector proteins to regulate gene expression. This code is interpreted by chromatin remodeling complexes and transcription factors that contain specialized domains (bromodomains for acetylation, chromodomains for methylation) to recognize specific modifications.
                </p>
            </div>
            
            <div class="key-points">
                <div class="key-points-title">Key Points:</div>
                <div class="key-point">H3K4me3 marks active promoters and gene activation</div>
                <div class="key-point">H3K27me3 marks Polycomb-mediated gene repression</div>
                <div class="key-point">H3K9me3 marks heterochromatin and gene silencing</div>
                <div class="key-point">Histone modifications are reversible and dynamic</div>
                <div class="key-point">Writer, reader, and eraser proteins regulate the histone code</div>
            </div>
        </div>

        <!-- Detailed Section 3: Chromatin States -->
        <div class="detailed-section">
            <h2 class="section-title">3. Chromatin States</h2>
            
            <div class="diagram-container">
                <svg class="svg-diagram" viewBox="0 0 800 300" xmlns="http://www.w3.org/2000/svg">
                    <!-- Euchromatin (left side) -->
                    <text x="200" y="30" text-anchor="middle" font-size="18" font-weight="bold" fill="#4CAF50">Euchromatin</text>
                    <text x="200" y="50" text-anchor="middle" font-size="14" fill="#666">(Open, Active)</text>
                    
                    <!-- Open chromatin structure -->
                    <g id="open-chromatin">
                        <circle cx="120" cy="120" r="25" fill="#81C784" opacity="0.7"/>
                        <circle cx="180" cy="120" r="25" fill="#81C784" opacity="0.7"/>
                        <circle cx="220" cy="120" r="25" fill="#81C784" opacity="0.7"/>
                        <circle cx="280" cy="120" r="25" fill="#81C784" opacity="0.7"/>
                        
                        <!-- DNA -->
                        <path d="M 95 120 Q 80 100 95 80" stroke="#1E64C8" stroke-width="2" fill="none"/>
                        <path d="M 145 120 Q 160 100 145 80" stroke="#1E64C8" stroke-width="2" fill="none"/>
                        <path d="M 195 120 Q 180 100 195 80" stroke="#1E64C8" stroke-width="2" fill="none"/>
                        <path d="M 255 120 Q 270 100 255 80" stroke="#1E64C8" stroke-width="2" fill="none"/>
                    </g>
                    
                    <!-- Transcription factors -->
                    <rect x="150" y="70" width="30" height="15" fill="#FFD93D" rx="3"/>
                    <text x="165" y="80" text-anchor="middle" font-size="10" font-weight="bold" fill="#333">TF</text>
                    <rect x="210" y="75" width="30" height="15" fill="#FFD93D" rx="3"/>
                    <text x="225" y="85" text-anchor="middle" font-size="10" font-weight="bold" fill="#333">TF</text>
                    
                    <!-- RNA polymerase -->
                    <path d="M 160 160 L 180 160 L 180 180 L 160 180 Z" fill="#FF6B6B"/>
                    <text x="170" y="173" text-anchor="middle" font-size="9" font-weight="bold" fill="white">Pol</text>
                    <path d="M 180 170 L 240 170" stroke="#FF6B6B" stroke-width="2" stroke-dasharray="5,5"/>
                    <text x="210" y="165" text-anchor="middle" font-size="11" fill="#FF6B6B" font-weight="bold">mRNA</text>
                    
                    <!-- Features -->
                    <text x="200" y="220" text-anchor="middle" font-size="13" fill="#333">• Loose DNA packaging</text>
                    <text x="200" y="240" text-anchor="middle" font-size="13" fill="#333">• Accessible to proteins</text>
                    <text x="200" y="260" text-anchor="middle" font-size="13" fill="#333">• Active transcription</text>
                    <text x="200" y="280" text-anchor="middle" font-size="13" fill="#333">• H3K4me3, acetylation</text>
                    
                    <!-- Dividing line -->
                    <line x1="400" y1="60" x2="400" y2="290" stroke="#ccc" stroke-width="2" stroke-dasharray="10,5"/>
                    
                    <!-- Heterochromatin (right side) -->
                    <text x="600" y="30" text-anchor="middle" font-size="18" font-weight="bold" fill="#E91E63">Heterochromatin</text>
                    <text x="600" y="50" text-anchor="middle" font-size="14" fill="#666">(Closed, Silent)</text>
                    
                    <!-- Condensed chromatin structure -->
                    <g id="closed-chromatin">
                        <circle cx="540" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="560" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="580" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="600" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="620" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="640" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        <circle cx="660" cy="130" r="25" fill="#F48FB1" opacity="0.9"/>
                        
                        <!-- Tightly packed DNA -->
                        <path d="M 520 130 Q 510 115 520 100" stroke="#1E64C8" stroke-width="2" fill="none"/>
                        <path d="M 540 130 Q 530 115 540 100" stroke="#1E64C8" stroke-width="2" fill="none"/>
                    </g>
                    
                    <!-- Blocked transcription -->
                    <line x1="520" y1="160" x2="680" y2="160" stroke="#E91E63" stroke-width="3"/>
                    <line x1="520" y1="157" x2="680" y2="163" stroke="#E91E63" stroke-width="3"/>
                    <text x="600" y="180" text-anchor="middle" font-size="11" fill="#E91E63" font-weight="bold">No transcription</text>
                    
                    <!-- Features -->
                    <text x="600" y="220" text-anchor="middle" font-size="13" fill="#333">• Tight DNA packaging</text>
                    <text x="600" y="240" text-anchor="middle" font-size="13" fill="#333">• Inaccessible to proteins</text>
                    <text x="600" y="260" text-anchor="middle" font-size="13" fill="#333">• Gene silencing</text>
                    <text x="600" y="280" text-anchor="middle" font-size="13" fill="#333">• H3K9me3, H3K27me3</text>
                </svg>
            </div>
            
            <p class="description">
                Chromatin exists in two major structural states that profoundly influence gene expression: euchromatin and heterochromatin. These states represent different levels of chromatin compaction and accessibility, with dynamic transitions between states serving as a key mechanism for gene regulation during development and in response to environmental signals.
            </p>
            
            <div class="subsection">
                <h3 class="subsection-title">Euchromatin</h3>
                <p class="description">
                    Euchromatin represents the "open" chromatin state characterized by loosely packed nucleosomes and high accessibility to transcription machinery. In euchromatic regions, DNA is less tightly associated with histones, allowing transcription factors and RNA polymerase to access regulatory elements and gene bodies. This state is associated with high levels of histone acetylation and H3K4 methylation, which recruit transcriptional activators and chromatin remodeling complexes.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">Heterochromatin</h3>
                <p class="description">
                    Heterochromatin represents the "closed" chromatin state with densely packed nucleosomes that restrict access to DNA. This state can be constitutive (permanently silenced regions like centromeres and telomeres) or facultative (reversibly silenced genes that can be reactivated). Heterochromatin is enriched in repressive histone marks like H3K9me3 and H3K27me3, and is often associated with DNA methylation and heterochromatin protein 1 (HP1) binding.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">Dynamic Transitions</h3>
                <p class="description">
                    Chromatin states are not fixed but undergo dynamic transitions in response to developmental cues, cell signaling, and environmental factors. These transitions are orchestrated by chromatin remodeling complexes (SWI/SNF, ISWI, CHD families) that use ATP hydrolysis to alter nucleosome positioning and by histone-modifying enzymes that add or remove specific modifications. These changes enable cells to establish and maintain cell-type-specific gene expression patterns.
                </p>
            </div>
            
            <div class="key-points">
                <div class="key-points-title">Key Points:</div>
                <div class="key-point">Chromatin states are cell-type and tissue-specific</div>
                <div class="key-point">Pioneer transcription factors can access closed chromatin</div>
                <div class="key-point">Chromatin remodeling complexes use ATP to move nucleosomes</div>
                <div class="key-point">Bivalent domains contain both active and repressive marks</div>
                <div class="key-point">Chromatin states are maintained through cell division</div>
            </div>
        </div>

        <!-- Detailed Section 4: Disease Implications -->
        <div class="detailed-section">
            <h2 class="section-title">4. Disease Implications</h2>
            
            <div class="diagram-container">
                <svg class="svg-diagram" viewBox="0 0 800 340" xmlns="http://www.w3.org/2000/svg">
                    <!-- Central DNA helix -->
                    <g id="dna-center">
                        <ellipse cx="400" cy="170" rx="60" ry="100" fill="none" stroke="#1E64C8" stroke-width="3"/>
                        <text x="400" y="175" text-anchor="middle" font-size="16" font-weight="bold" fill="#1E64C8">Normal</text>
                        <text x="400" y="192" text-anchor="middle" font-size="16" font-weight="bold" fill="#1E64C8">Epigenome</text>
                    </g>
                    
                    <!-- Cancer (top-left) -->
                    <circle cx="150" cy="70" r="50" fill="#FF6B6B" opacity="0.2" stroke="#FF6B6B" stroke-width="3"/>
                    <text x="150" y="65" text-anchor="middle" font-size="15" font-weight="bold" fill="#FF6B6B">Cancer</text>
                    <text x="150" y="82" text-anchor="middle" font-size="11" fill="#333">Aberrant</text>
                    <text x="150" y="95" text-anchor="middle" font-size="11" fill="#333">methylation</text>
                    <line x1="340" y1="120" x2="190" y2="85" stroke="#FF6B6B" stroke-width="2" marker-end="url(#arrowred)"/>
                    
                    <!-- Imprinting disorders (top-right) -->
                    <circle cx="650" cy="70" r="50" fill="#9B59B6" opacity="0.2" stroke="#9B59B6" stroke-width="3"/>
                    <text x="650" y="65" text-anchor="middle" font-size="15" font-weight="bold" fill="#9B59B6">Imprinting</text>
                    <text x="650" y="82" text-anchor="middle" font-size="11" fill="#333">Parent-specific</text>
                    <text x="650" y="95" text-anchor="middle" font-size="11" fill="#333">expression</text>
                    <line x1="460" y1="120" x2="610" y2="85" stroke="#9B59B6" stroke-width="2" marker-end="url(#arrowpurple)"/>
                    
                    <!-- X-inactivation (bottom-left) -->
                    <circle cx="150" cy="270" r="50" fill="#E91E63" opacity="0.2" stroke="#E91E63" stroke-width="3"/>
                    <text x="150" y="265" text-anchor="middle" font-size="15" font-weight="bold" fill="#E91E63">X-Chromosome</text>
                    <text x="150" y="282" text-anchor="middle" font-size="11" fill="#333">Dosage</text>
                    <text x="150" y="295" text-anchor="middle" font-size="11" fill="#333">compensation</text>
                    <line x1="340" y1="220" x2="190" y2="255" stroke="#E91E63" stroke-width="2" marker-end="url(#arrowpink)"/>
                    
                    <!-- Environmental influences (bottom-right) -->
                    <circle cx="650" cy="270" r="50" fill="#27AE60" opacity="0.2" stroke="#27AE60" stroke-width="3"/>
                    <text x="650" y="265" text-anchor="middle" font-size="15" font-weight="bold" fill="#27AE60">Environment</text>
                    <text x="650" y="282" text-anchor="middle" font-size="11" fill="#333">Diet, toxins,</text>
                    <text x="650" y="295" text-anchor="middle" font-size="11" fill="#333">stress</text>
                    <line x1="460" y1="220" x2="610" y2="255" stroke="#27AE60" stroke-width="2" marker-end="url(#arrowgreen)"/>
                    
                    <!-- Arrow markers -->
                    <defs>
                        <marker id="arrowred" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#FF6B6B" />
                        </marker>
                        <marker id="arrowpurple" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#9B59B6" />
                        </marker>
                        <marker id="arrowpink" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#E91E63" />
                        </marker>
                        <marker id="arrowgreen" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#27AE60" />
                        </marker>
                    </defs>
                    
                    <!-- Title -->
                    <text x="400" y="25" text-anchor="middle" font-size="18" font-weight="bold" fill="#1E64C8">Epigenetic Dysregulation in Disease</text>
                </svg>
            </div>
            
            <p class="description">
                Epigenetic mechanisms play crucial roles in maintaining normal cellular function, and their dysregulation is implicated in numerous human diseases. Unlike genetic mutations that alter DNA sequence, epigenetic changes are potentially reversible, making them attractive therapeutic targets. Understanding disease-associated epigenetic alterations has opened new avenues for diagnosis, prognosis, and treatment.
            </p>
            
            <div class="subsection">
                <h3 class="subsection-title">Cancer and Aberrant Methylation</h3>
                <p class="description">
                    Cancer cells exhibit widespread epigenetic abnormalities, including global DNA hypomethylation coupled with regional hypermethylation at CpG islands. Hypermethylation of tumor suppressor gene promoters (such as VHL, BRCA1, MLH1, and CDKN2A) leads to transcriptional silencing without genetic mutation, effectively inactivating critical growth regulatory pathways. This epigenetic silencing can occur early in tumorigenesis and contribute to cancer initiation and progression.
                </p>
                <p class="description">
                    Conversely, global hypomethylation can lead to chromosomal instability, activation of transposable elements, and loss of genomic integrity. Histone modification patterns are also altered in cancer, with changes in HAT/HDAC activity and aberrant recruitment of Polycomb repressive complexes affecting gene expression programs that control cell proliferation, apoptosis, and differentiation.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">Imprinting Disorders</h3>
                <p class="description">
                    Genomic imprinting is an epigenetic phenomenon where certain genes are expressed in a parent-of-origin-specific manner. Imprinted genes are critical for normal development and growth, and their dysregulation causes several human disorders. Prader-Willi syndrome and Angelman syndrome result from deletions or epimutations affecting the 15q11-q13 region, with different phenotypes depending on which parent's chromosome is affected.
                </p>
                <p class="description">
                    Beckwith-Wiedemann syndrome, characterized by overgrowth and increased cancer risk, results from loss of imprinting at the 11p15.5 locus. These disorders highlight the importance of properly established and maintained methylation patterns at imprinting control regions during gamete formation and early development.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">X-Chromosome Inactivation</h3>
                <p class="description">
                    In female mammals, one X chromosome is randomly inactivated in each cell to achieve dosage compensation with males (who have only one X chromosome). This process, mediated by the long non-coding RNA XIST and involving extensive DNA methylation and repressive histone modifications, converts one X chromosome into facultative heterochromatin (the Barr body). Defects in X-inactivation can lead to various developmental disorders and skewed inactivation patterns are observed in some cancers and autoimmune diseases.
                </p>
            </div>
            
            <div class="subsection">
                <h3 class="subsection-title">Environmental Influences</h3>
                <p class="description">
                    Environmental factors including nutrition, toxins, stress, and lifestyle can induce epigenetic changes that affect health and disease susceptibility. The Dutch Hunger Winter studies demonstrated that prenatal famine exposure leads to persistent DNA methylation changes associated with metabolic disorders decades later. Maternal diet, particularly folate and methyl donor availability, influences offspring epigenomes and disease risk.
                </p>
                <p class="description">
                    Environmental toxicants like bisphenol A (BPA), heavy metals, and air pollutants can alter epigenetic patterns. These environmentally-induced changes may be transgenerationally inherited, potentially explaining some phenotypic variation and disease susceptibility that cannot be attributed to genetic variation alone. Understanding these mechanisms has important implications for preventive medicine and public health.
                </p>
            </div>
            
            <div class="key-points">
                <div class="key-points-title">Key Points:</div>
                <div class="key-point">Epigenetic drugs (DNMT inhibitors, HDAC inhibitors) are approved for cancer treatment</div>
                <div class="key-point">Liquid biopsies detect aberrant methylation patterns for early cancer diagnosis</div>
                <div class="key-point">Epigenetic age (DNA methylation clocks) predicts biological aging</div>
                <div class="key-point">Transgenerational epigenetic inheritance affects disease susceptibility</div>
                <div class="key-point">Personalized epigenetic therapies represent a growing field</div>
            </div>
        </div>

        <!-- Footer -->
        <div style="margin-top: 50px; padding: 20px; background: #f8f9fb; border-radius: 8px; text-align: center;">
            <p style="color: #666; font-size: 14px;">
                Epigenetic modifications represent a sophisticated layer of gene regulation that bridges genetics and environment, 
                with profound implications for development, disease, and therapeutic intervention.
            </p>
        </div>
    </div>
</body>
</html>